D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VIRX holding history

Viracta Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VIRX overview All 13F holders of VIRX Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of VIRX by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−26,883−100.0%	Sold out	Holders
Q4 2021	26,883	$98.0K	<0.1%	−9,379−25.9%	Reduced	Holders
Q3 2021	36,262	$291.0K	<0.1%	+36,262	New	Holders